New products for wound treatment in diabetes
03.12.2009 11:34
GlucoMetrix Pharma GmbH is launching its new medical product range BIOSept for diabetic wound treatment this year
The certification company LGA Intercert mbh issues certification for the four products BioSept wound gel, BioSept wound spray, BioSept wound rinse and BioSept mouth rinse for the successful treatment of open wounds in diabetes mellitus patients. Sales will start this year.
GlucoMetrix PharmaGmbH from Ruhpolding in Upper Bavaria has certified its four wound healing products, BioSept wound gel, BioSept wound spray, BioSept wound rinse and BioSept mouth rinse, according to EN ISO13485:2003+AC2007. The notified body LGA-Intercert issued the relevant certificates on November 24th.
This means that the life science company is able to offer and sell this BioSept product range on the market as a Class IIb medical device. “Putting the BIOSept product range on the market is a very important and gratifying step for our young company. We will soon start delivery and sales,” says Peter Paul Schikora, Managing Director of GlucoMetrix Pharma GmbH. “At the same time, we will begin the targeted advertising and marketing campaigns aimed at the target groups.”
GlucoMetrix Pharma GmbH has set itself the goal of sustainably increasing the quality of life of diabetics. The BioSept products were also developed according to this high standard. All products in the new BipoSept range help millions of diabetics with their very common problems: They support the care and natural healing process of difficult-to-heal diabetic wounds. The entire range of BIOSept products consists of purely natural components and does not contain any preservatives or colorings and is therefore also very suitable for allergy sufferers.
An amputation due to diabetic foot syndrome takes place in Germany every 19 minutes. “The number could be reduced by at least a third if diseased feet were discovered early and treated accordingly. GlucoMetrix Pharma GmbH is working on a consistent concept for wound care for diabetics. The first four products are now available, further, equally effective product innovations will follow soon,” says GlucoMetrix Pharma Managing Director Peter Paul Schikora.”
A product from the BioSept product range, the BIOSept mouthwash also helps to counteract periodontitis. This is an extremely important factor for diabetics. Professor Dr. James Deschner from the University of Bonn pointed out on the occasion of Dental Health Day on September 25th. He recommends that diabetics have their oral health checked regularly. Because gum inflammation can raise your blood sugar level to a serious level. In a so-called periodontitis, bacteria from the inflamed gum pockets migrate into the body via the bloodstream. Together with the inflammatory messengers, they inhibit insulin action, the scientist suspects. As a result, the blood sugar level rises. Periodontitis must therefore be viewed as a further disadvantage of diabetes, emphasizes Deschner. Studies have shown, however, that blood sugar levels can be reduced if the infection in the mouth is eliminated.
What applies to diabetics is also important to non-diabetics. Any inflammatory germs in the bloodstream can support inflammation in organs or the threatening arteriosclerosis. This is an important aspect of maintaining health, especially for older people, and therefore even non-diabetics can use BIOSept products without hesitation.